MedPath

Researching trained immunity in SLE patients

Conditions
Systemic lupus erythematosus
lupus
10003816
Registration Number
NL-OMON53281
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Age between 18 and 70 years old.
Positive SLE diagnosis.

Exclusion Criteria

Lack of informed consent
Current infection
CKD stage 5 or dialysis
Pregnancy
Active cancer

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. What are the differences in the transcriptome of circulating monocytes from<br /><br>SLE patients when the disease is in remission or when the disease is active<br /><br>(flares), and how does this differ with the transcriptome of circulating<br /><br>monocytes from healthy individuals?<br /><br><br /><br>2. What are the differences in the epigenome of circulating monocytes from SLE<br /><br>patients when the disease is in remission or when the disease is active<br /><br>(flares), and how does this differ with the epigenome of circulating monocytes<br /><br>from healthy individuals?<br /><br><br /><br>3. What are the differences in the cytokine response of circulating monocytes<br /><br>from SLE patients when the disease is in remission or when the disease is<br /><br>active (flares), and how does this differ with the response of circulating<br /><br>monocytes from healthy individuals?</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Are there correlations between the trained immunity profile of circulating<br /><br>monocytes (identified by transcriptome, epigenetics, and cytokine response) and<br /><br>the degree of current disease activity in clinical variables of SLE patients?<br /><br><br /><br>2. Are there correlations between the trained immunity profile of circulating<br /><br>monocytes (identified on the basis of the transcriptome, epigenetics, and<br /><br>cytokine response) and the risk of the occurrence of flares in the future.<br /><br><br /><br>3. Are there correlations between the trained immunity profile of circulating<br /><br>monocytes (identified based on the transcriptome, epigenetics, and cytokine<br /><br>response) and inflammatory markers in the blood. </p><br>
© Copyright 2025. All Rights Reserved by MedPath